Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027651 (
tumor
)
685,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The kinetic properties of hexokinase of L1210 ascites
tumor
cells propagated in DBA/2HaD mice are altered by treatment of the mice with the modified nucleoside N6-(delta2-isopentenyl)-adensone (IPA). Relative to animals not treated with IPA, ascites cell hexokinase showed an increased affinity for
ATP
and a decreased affinity for glucose as a result of IPA treatment. The heat stability of the enzyme was different in treated and untreated mice. It was concluded that IPA treatment may either produce changes in enzyme conformation which resulted in a change in control mechanisms or may induce the formation of a hexokinase isoenzyme.
...
PMID:Effect of N6-(delta2-isopentenyl)adenosine treatment in vivo on hexokinase activity of mouse L 1210 cells. 105 42
We reported earlier that the addition of double-stranded RNA and
ATP
increases the endonuclease activity more in an extract of Ehrlich ascites
tumor
cells which have been treated with an interferon preparation than in a comparable extract from control cells. We report here that the addition of double-stranded RNA to an extract from Ehrlich ascites
tumor
cells which have been treated with an interferon preparation [or with the interferon inducer poly(I)-poly(C)] promotes the phosphorylation by [gamma-32P]
ATP
of at least two proteins: P1 (molecular weight of 64,000) and P2 (molecular weight of 37,000). Double-stranded RNA also promotes the phosphorylation of at least one (i.e., P1) of these two proteins in an extract from cells which have not been treated with interferon, but the extent of phosphorylation is much smaller. Double-stranded RNA which has been degraded by RNase III, or DNA, does not promote the phosphorylation.
...
PMID:Interferon, double-stranded RNA, and protein phosphorylation. 106 6
The effects of cell injury on Ehrlich ascites
tumor
cell mitochondria were studied using two model injuries: (1) interference with cell membrane function and (2) inhibition of
ATP
synthesis with specific mitochondrial inhibitors. These studies indicate a good correlation between level of
ATP
and number of swollen mitochondria and between swollen mitochondria and occurrence of flocculent densities. No correlation existed between total ADP level and percentage of condensed mitochondria if all ADP values were considered, although a biphasic relationship appeared to exist between the number of condensed mitochondria and the levels of
ATP
. The study suggests a reproducible sequence of mitochondrial events following either inhibition of
ATP
synthesis or induction of cell membrane permeability with the nonpenetrating, membrane-damaging agent p-chloromercuribenzene sulfonic acid. These include the rapid appearance of condensed mitochondria, the reinflation of these to resemble orthodox mitochondria, and the occurrence of high amplitude swelling followed by flocculent densities or calcification, or both. Calcification did not occur when
ATP
synthesis was inhibited but did occur when the cell membrane was damaged with p-chloromercuribenzene sulfonic acid. It is suggested that the early mitochondrial condensation is related to loss of ions and water from the mitochondrial inner compartment following inhibition of active accumulation systems. It is furthermore suggested that the appearance of the condensed mitochondrial state can be taken as evidence of the intactness of the mitochondrial respiratory chain. The occurrence of swelling indicates structural changes in the mitochondrial inner membrane which occur following loss of ability for
ATP
synthesis.
...
PMID:Studies on the pathogenesis of cell injury: effects of inhibitors of metabolism and membrane function on the mitochondria of Ehrlich ascites tumor cells. 111 9
A pyrimidine nucleoside monophosphate kinase has been purified 2100-fold from rat liver. With
ATP
and dATP as phosphate donors the kinase uses CMP, dCMP, and UMP as phosphate acceptors. Ara-CMP is also phosphorylated by the kinase. In contrast to dCMP and UMP, CMP can be phosphorylated by dCTP. CTP and ara-CTP cannot substitute for dCTP. The stringent specificity of the phosphate donor site for
ATP
and dATP is lost when CMP serves as acceptor. All nucleoside triphosphates act as donors to a significant extent. No evidence has been found to suggest more than one enzyme. All activities, to different degrees, are strictly dependent upon preincubation at 37 degrees with a sulfhydryl reducing agent. Various reagents (85 mM) are ranked in order of increasing effectiveness of reactivation as follows: dithiothretiol greater than glutathione larger than or equal to 2-mercaptoethanol greater than L-cysteine greater than DL-alpha-lipoic acid. A NADP+-dependent thioredoxin (17 muM)-thioredoxin reductase system from Novikoff ascites rat
tumor
was found to be the most powerful reducing agent tested. CTP, dCTP, UTP, and dTTP (1 mM) do not affect the kinase activity regardless of the phosphate acceptor.
...
PMID:A pyrimidine nucleoside monophosphate kinase from rat liver. 112 84
In a model system consisting of highly coupled rat liver mitochondria respiring in the presence of substrate, pyruvate kinase, phosphoenolpyruvate,
ATP
, hexokinase and glucose, the increase in the mitochondrial concentration results in a progressive decrease in the activity of pyruvate kinase. These results are in accord with a role of pyruvate kinase as a determinant of glycolytic activity by competing with mitochondrial oxidative phosphorylation for the available ADP. The addition of adequate amounts of the amino acids, cysteine, alanine and phenylalanine, known as inhibitors of pyruvate kinase, to living Ehrlich ascites
tumor
cell suspensions results in a stimulation of the respiratory rate and in a decrease of the glycolytic rate of the cells. Concomitant with these changes, there is an accumulation of intracellular phosphoenolpyruvate and ADP, and a decrease in pyruvate and
ATP
. These results provide additional evidence for paying attention to pyruvate kinase as another key enzyme whose properties and activities may be major determinants for the control of glycolysis and the Crabtree and Pasteur effects of
tumor
cells.
...
PMID:Stimulation of tumor-cell respiration by inhibitors of pyruvate kinase. 117 5
A non-histone protein has been isolated from Ehrlich ascites
tumor
chromatin. The minimum molecular weight of this non-histone protein, estimated by sodium dodecyl sulfate gel electrophoresis and amino acid analysis, is approximately 10 to 11,000. This non-histone protein is acidic, contains 2.7% alkalilabile phosphorus, binds to DNA, and inhibits transcription of DNA in vitro by the homologous RNA polymerase. The per cent inhibition of RNA synthesis is not affected by increasing amounts of RNA polymerase, but is reduced by addition of excess DNA. In the presence of the non-histone protein, incorporation of [gamma-32P]
ATP
into RNA in the in vitro RNA synthesizing system is inhibited, with no apparent change in the average chain length of the RNA product. Inhibition of RNA synthesis is completely eliminated if the DNA template is allowed to interact with
ATP
prior to the addition of the non-histone protein. These results indicate that the observed repression of in vitro RNA synthesis is due to the effect of the non-histone protein on the DNA, inhibiting the initiation of RNA chain formation.
...
PMID:Inhibition of transcription in vitro by a non-histone protein isolated from Ehrlich ascites tumor chromatin. 119 69
Effect of various metabolic inhibitors on the agglutination of rat ascites
tumor
cells mediated by concanavalin A and Ricinus communis agglutinin was studied using a quantitative assay method for agglutination in which turbidity of cell suspension is measured. Cell agglutination was inhibited by low temperature, cytochalasin B and inhibitors of energy generating systems without affecting lectin binding, and agglutination was not affected by hydroxyurea, actinomycin D or cycloheximide. The inhibitors of energy generating systems decreased the cellular
ATP
level and inhibited macromolecular synthesis under the conditions where they inhibited the agglutinations. In contrast, cytochalasin B did not depress the cellular
ATP
level nor inhibit RNA and protein syntheses. These results suggest that the agglutination is associated with cellular energy dependent processes other than macromolecular synthesis; probably with some cellular surface movements participated by microfilament activity.
...
PMID:Cellular energy dependent agglutination of rat ascites tumor cells mediated by concanavalin A and Ricinus communis agglutinin. 120 Dec 83
The membrane potential of Ehrlich ascites
tumor
cells and the effects of valinomycin and ouabain upon it have been determined. The membrane potential in control cells was 12.0 mV, inside negative. Neither valinomycin nor ouabain alone affected this value. However, valinomycin and ouabain in combination resulted in a slight hyperpolarization of the membrane. Concomitant determinations of cellular Na+, K+ and Cl- showed that valinomycin induced net losses of K+ and Cl- and a net gain in Na+ when compared to ouabain-inhibited cells. K+ permeability was increased by approximately 30% in the presence of valinomycin. In addition, valinomycin caused a rapid depletion of cellular
ATP
. Inhibition of Na/K transport by ouabain was without sparing effect on the rate of
ATP
depletion. Possible mechanisms for the electroneutral increase in K+ permeability induced by valinomycin are discussed.
...
PMID:Direct measurement of the membrane potential of Ehrlich ascites tumor cells: lack of effect of valinomycin and ouabain. 123 75
Microcystin-LR (MC-LR), an inhibitor of protein phosphatases 1 and 2A, is a potent
tumor
promoter in rat liver initiated with diethylnitrosamine. To understand its biochemical process in hepatocytes, primary cultured rat hepatocytes were treated with MC-LR. MC-LR (1 microM) induced phosphorylation of various proteins. Two 55 and 49 kDa proteins were phosphorylated at a 3-fold higher rate than other proteins, and these proteins were identified to be cytokeratins 8 and 18 respectively, by immunoprecipitation and Western blot analysis using monoclonal anti-cytokeratin 8 and 18 antibodies. The basic cytokeratins 8 and 18 showed pI 6.4 and 5.4 respectively, in two-dimensional gel electrophoresis. MC-LR dose dependently increased phosphorylation of cytokeratins 8 and 18 in a cell-free system by incubation with a cytosolic fraction of rat liver containing both protein kinases and protein phosphatases 1 and 2A, and with [gamma-32P]
ATP
. Cytokeratins 8 and 18 were target proteins for phosphorylation induced by inhibition of protein phosphatases 1 and 2A, in vitro and in rat hepatocytes. Thus, the treatment of rat hepatocytes with MC-LR induced hyperphosphorylation of cytokeratins 8 and 18 associated with morphological changes, indicating that intermediate filament networks were rearranged in the cytoplasm. The hyperphosphorylation of cytokeratins is a significant biochemical process associated with liver
tumor
promotion.
...
PMID:Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumor promoter, in primary cultured rat hepatocytes. 128 96
Mechanisms contributing to reduced cytotoxic drug accumulation were studied in two multidrug-resistant (MDR) human lung cancer cell lines without P-glycoprotein expression. In these (non-small cell) SW-1573/2R120 and (small cell) GLC4/ADR MDR cells, the steady-state accumulation of [14C]daunorubicin was 30 and 12%, respectively, of that in the parent cells. When cells, at steady state, were permeabilized with digitonin, the amount of daunorubicin binding increased only in the resistant cells. The reduced accumulation of daunorubicin in the SW-1573/2R120 and GLC4/ADR cells was accompanied by a lower initial (2 min) uptake rate of this drug. No difference in initial efflux rate of daunorubicin from preloaded cells could be detected between sensitive and resistant SW-1573 cells. However, daunorubicin was extruded 5-fold faster from GLC4/ADR cells than from the parental cells. In the presence of the energy metabolism inhibitors sodium azide and deoxyglucose, the reduced daunorubicin accumulations in the SW-1573/2R120 and GLC4/ADR MDR cells were (almost) completely reversed. The effects of these inhibitors on drug uptake were already apparent during the earliest measured time points (less than 15 s). Also, the enhanced efflux of daunorubicin from GLC4/ADR cells was inhibited. In
ATP
-depleted cells, the intracellular pH was lowered by approximately 0.3 units in resistant as well as in sensitive cells. The lower intracellular pH, however, could not account for the increase in daunorubicin accumulation in the resistant cells. Also, for vincristine and etoposide, the increases in drug accumulation under energy-deprived conditions were more pronounced in the resistant SW-1573/2R120 cells than in the parent SW-1573 cells. These results suggest that accumulation of drugs in the non-P-glycoprotein MDR human lung carcinoma cell lines SW-1573/2R120 and GLC4/ADR is reduced by an energy-dependent drug export mechanism which prevents efficient transport of drug to the target. Since P-glycoprotein expression in lung tumors is generally low, these MDR lung cancer cell lines can be used as a model to study alternative mechanisms leading to multidrug resistance in this
tumor
type.
...
PMID:Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. 130 22
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>